These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4064287)

  • 21. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining electrophoresis with detection under ultraviolet light and multiple ultrafiltration for isolation of humic fluorescence fractions.
    Trubetskaya OE; Shaloiko LA; Demin DV; Marchenkov VV; Proskuryakov II; Coelho C; Trubetskoj OA
    Anal Chim Acta; 2011 Apr; 690(2):263-8. PubMed ID: 21435485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients.
    Zimmerman L; Egestad B; Jörnvall H; Bergström J
    Clin Nephrol; 1989 Sep; 32(3):124-8. PubMed ID: 2791363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid-chromatographic study of fluorescent materials in uremic fluids.
    Swan JS; Kragten EY; Veening H
    Clin Chem; 1983 Jun; 29(6):1082-4. PubMed ID: 6851098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Many hitherto unknown peptides are principal constituents of uremic "middle molecules".
    Menyhárt J; Gróf J
    Clin Chem; 1981 Oct; 27(10):1712-6. PubMed ID: 7285323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of dialysis treatment in uremic patients by gel filtration of serum.
    Osada J; Gea T; Sanz C; Millan I; Botella J
    Clin Chem; 1990 Nov; 36(11):1906-10. PubMed ID: 2242568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of blood toxicity in chronic uremia by an improved chromatographic method.
    Politi L; D'Angelo AR; Caramia M; Molinaro M; Nicoletti R; Cerulli N; Moriggi M; Scandurra R
    Clin Exp Dial Apheresis; 1981; 5(3):277-84. PubMed ID: 7333038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluorescent chromatogram profiles of uremic hemodialyzates and cirrhosis urines].
    Konobu K; Yamamoto E; Matsumoto T
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1017-23. PubMed ID: 2263023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and chromatographic analysis of unidentified fluorescence in biological fluids of patients with chronic renal disease.
    Schwertner HA
    Nephron; 1982; 31(3):209-11. PubMed ID: 7121667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isotachophoretic pattern of LDH inhibiting fractions obtained from uremic ultrafiltrate by gelchromatography.
    De Smet R; van Landschoot N; van der Stiggel G; Ringoir S
    Int J Artif Organs; 1983 Mar; 6(2):67-70. PubMed ID: 6840893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.
    Hsu CH; Vanholder R; Patel S; De Smet RR; Sandra P; Ringoir SM
    Kidney Int; 1991 Nov; 40(5):868-73. PubMed ID: 1762291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in heart rate variability in chronic uremic patients during ultrafiltration and hemodialysis.
    Galetta F; Cupisti A; Franzoni F; Morelli E; Caprioli R; Rindi P; Barsotti G
    Blood Purif; 2001; 19(4):395-400. PubMed ID: 11574736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis.
    Zoccali C; Mallamaci F; Ciccarelli M; Parlongo S; Salnitro F
    Clin Nephrol; 1992 Apr; 37(4):198-203. PubMed ID: 1533821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
    Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
    Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in dissolved fractions of human enamel.
    Hafström-Björkman U; Sundström F; ten Bosch JJ
    Acta Odontol Scand; 1991 Jun; 49(3):133-8. PubMed ID: 1652879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease of polymorphonuclear leukocyte membrane fluidity in uremic patients on hemodialysis.
    Masuda M; Komiyama Y; Murakami T; Murata K
    Nephron; 1990; 54(1):36-41. PubMed ID: 2296343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profiling of uremic serum by high-resolution gas chromatography-electron-impact, chemical ionization mass spectrometry.
    Schoots AC; Mikkers FE; Cramers CA; Ringoir S
    J Chromatogr; 1979 Sep; 164(1):1-8. PubMed ID: 541389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorometric study of serum in patients with chronic renal failure.
    Hadjivassiliou AG; Digenis GE; Mayopoulou-Symvoulidis D; Voudiclari S; Tsaparas N; Symvoulidis A
    Clin Nephrol; 1984 Jul; 22(1):39-43. PubMed ID: 6478660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.